For keen IPO investors, here is some exciting IPO news. Three prominent companies, Mamaearth, Indegene, and Vishnu Prakash R Punglia, have received coveted approval from SEBI for their upcoming IPO launches. Let’s dive into the details of these game-changing developments in the Indian capital markets!
Highlights of this IPO News
- Mamaearth’s IPO, worth Rs 400 crore, gets Sebi’s green signal.
- Honasa Consumer expands with five new brands in the beauty sector.
- Indegene’s IPO of Rs 950 crore to fuel growth and debt repayment.
- Vishnu Prakash R Punglia is set to launch an IPO for the fresh issue of 3.12 crore shares.
- SEBI approval paves the way for exciting opportunities in the Indian capital markets.
Honasa Consumer, a digital-first beauty and personal care company that owns the popular brand Mamaearth, has received the green signal from SEBI-Securities and Exchange Board of India for its IPO- Initial Public Offering (IPO). The IPO includes a fresh issuance of shares amounting Rs 400 crore and an offer for sale -OFS of 4.68 crore shares by promoters and investors.
Mamaearth IPO Valuation
Before filing the IPO papers with the Registrar of Companies, the company may consider raising Rs 80 crore through a pre-IPO placement, which could reduce the size of the fresh issue accordingly.
The objective of Mamaearth IPO
The proceeds from the fresh issue of Mamaeart IPO are aimed at advertising expenses to enhance brand awareness, setting up new exclusive brand outlets (EBOs), investing in subsidiary Bhabani Blunt Hairdressing (BBlunt) to establish new salons, and for general corporate purposes.
Honasa Consumer is digital-first beauty and personal care company in India based on its revenue from operations for FY22. It has expanded its portfolio with five new brands, including The Derma Co, Aqualogica, Ayuga, BBlunt, and Dr. Sheth’s, in addition to Mamaearth, since its launch in 2016.
Indegene, a life sciences commercialisation company, has also received approval from SEBI for its IPO. The IPO consists of a fresh issuance of shares worth Rs 950 crore and an offer for sale of 3.63 crore shares from existing shareholders, including Vida Trustee, BPC Genesis Fund, and CA Dawn Investments.
The Objective of Indegene IPO
The proceeds from the fresh issue of Indegene IPO will be utilised for debt repayment, capital expenditure, acquiring additional shares in DT Associates through its subsidiary ILSL Holdings Inc, and for general corporate purposes and growth opportunities. Indegene boasts client relationships with 19 out of the world’s 20 largest bio-pharmaceutical companies by revenue for the financial year 2021, with these 19 clients contributing over 70 percent of the company’s total revenue in FY22.
Vishnu Prakash R Punglia IPO
Vishnu Prakash R Punglia, an engineering, procurement, and construction company, has also received approval from Sebi for its IPO. The IPO consists of only a fresh issue of 3.12 crore equity shares.
Objective of Vishnu Prakash R Punglia IPO
The funds raised from the IPO will be used for purchasing equipment and machinery, meeting working capital requirements, and for general corporate purposes.
These approvals from SEBI mark a significant step for the companies’ IPO plans, enabling them to move forward with their public share offerings in the Indian capital markets.
How Can You Invest?
To invest in upcoming IPOs of 2023, you can start with an online trading platform that offers features like zero brokerage trading, a free DEMAT account, and AI-powered stock market predictions and signals.
SEBIs approval for Mamaearth, Indegene, and Vishnu Prakash R Punglia’s IPOs signifies a significant milestone in their growth journey. Investors can look forward to exciting prospects in the dynamic Indian capital markets with these promising offerings.
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.